Dysbiosis as a common pathogenetic mechanism in psoriasis and gastrointestinal diseases

Keywords

Psoriasis / gastrointestinal diseases / inflammatory bowel disease / Crohn’s disease / dysbiosis

References

[1] Sabooniha F. Psoriasis, bone and bowel: a comprehensive review and new insights. Explor Musculoskeletal Dis. 2024; 2: 1-19.

[2] Chen YJ, Ho HJ, Tseng CH, Lai ZL, Shieh JJ, Wu CY. Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients. Exp Dermatol. 2018; 27: 1336-43.

[3] Shapiro J, Cohen NA, Shalev V, Uzan A, Koren O, Maharshak N. Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls. J Dermatol. 2019; 46: 595-603.

[4] Zhou L, Zhang M, Wang Y, Dorfman RG, Liu H, Yu T, et al. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. Inflamm Bowel Dis. 2018; 24: 1926-40.

[5] Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol. 2021; 21: 78.

[6] Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease. Arthritis Rheumatol. 2015; 67: 128-39.

[7] Mao R, Yu Q, Li J. The causal relationship between gut microbiota and inflammatory dermatoses: a Mendelian randomization study. Front Immunol. 2023; 14: 1231848.